
CAS 61177-44-4
:Acide 4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylique, 3-(2-hydroxyéthylidène)-7-oxo-, sel de lithium (1:1), (2R,3Z,5R)-
- 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, lithium salt (1:1), (2R,3Z,5R)-
- 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monolithium salt, (2R,3Z,5R)-
- 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monolithium salt, [2R-(2α,3Z,5α)]-
- Lithium (2R-(2alpha,3(Z),5alpha))-3-(2-hydroxyethylidene)-4-oxa-7-oxo-1-azabicyclo(3.2.0)heptane-2-carboxylate
- Lithium clavulanate
Clavulanate Lithium
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C8H8NO5·LiCouleur et forme :White Light Yellow PowderMasse moléculaire :205.05625lithium [2R-(2α,3(Z),5α)]-3-(2-hydroxyethylidene)-4-oxa-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
CAS :Formule :C8H8LiNO5Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :205.0938Clavulanate lithium
CAS :Clavulanate lithium (Clavulanic acid lithium) is an inhibitor of β-lactamase.Formule :C8H8LiNO5Degré de pureté :99.79%Couleur et forme :SolidMasse moléculaire :205.09Clavulanate Lithium
CAS :Formule :C8H8NO5·LiCouleur et forme :White To Off-White SolidMasse moléculaire :198.16 6.94Clavulanate Lithium
CAS :Produit contrôléStability Hygroscopic
Applications Clavulanate Lithium is used as an antibacterial compound against a β-lactamase producing strain of Staphylococcus aureus.
References Cuffini, A. et al.: Microbios., 87, 31 (1996); Rodriguez, M. et al.: Int. J. Antimicrob. Agents., 29 332 (2007);Formule :C8H8NO5·LiCouleur et forme :Off-WhiteMasse moléculaire :205.09Clavulanate Lithium
CAS :Clavulanate lithium is an antibiotic that inhibits the growth of bacteria by binding to penicillin-binding proteins. It is a prodrug that is hydrolyzed in vivo to clavulanic acid, its active form. The inhibitory properties of clavulanate lithium are similar to those of amoxicillin, but it has greater activity against pseudomonas aeruginosa and Staphylococcus aureus. Clavulanate lithium has been shown to increase the plasma concentrations of amoxicillin when used in combination with this drug. It is also effective against a variety of bacterial infections, including Escherichia coli, Proteus mirabilis, Enterobacter cloacae, and Staphylococcus aureus isolates. Clavulanate lithium can be used as an adjunct therapy for the treatment of respiratory tract infections caused by common viruses such as influenza and rhinovirus. Clavulanate
Formule :C8H9NO5•LiDegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :206.1 g/mol










